Original Articles

You have full text access to this OnlineOpen article

Hepatosplenic γδ T-cell lymphoma after liver transplantation: Report of the first 2 cases and review of the literature

  1. Philip R. Roelandt1,
  2. Johan Maertens2,
  3. Peter Vandenberghe3,
  4. Chris Verslype1,
  5. Tania Roskams4,
  6. Raymond Aerts5,
  7. Frederik Nevens1,
  8. Daan Dierickx2,†,*

Article first published online: 26 JUN 2009

DOI: 10.1002/lt.21748

Issue

Liver Transplantation

Liver Transplantation

Volume 15, Issue 7, pages 686–692, July 2009

Additional Information

How to Cite

Roelandt, P. R., Maertens, J., Vandenberghe, P., Verslype, C., Roskams, T., Aerts, R., Nevens, F. and Dierickx, D. (2009), Hepatosplenic γδ T-cell lymphoma after liver transplantation: Report of the first 2 cases and review of the literature. Liver Transpl, 15: 686–692. doi: 10.1002/lt.21748

Author Information

  1. 1

    Department of Hepatology, University Hospital Gasthuisberg, Leuven, Belgium

  2. 2

    Department of Haematology, University Hospital Gasthuisberg, Leuven, Belgium

  3. 3

    Department of Human Genetics, University Hospital Gasthuisberg, Leuven, Belgium

  4. 4

    Department of Anatomopathology, University Hospital Gasthuisberg, Leuven, Belgium

  5. 5

    Department of Abdominal Transplantation Surgery, University Hospital Gasthuisberg, Leuven, Belgium

  1. †

    Telephone: 0032 16/34.68.80; FAX: 0032 16/34.68.85

*UZ Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium

Publication History

  1. Issue published online: 26 JUN 2009
  2. Article first published online: 26 JUN 2009
  3. Manuscript Accepted: 22 DEC 2008
  4. Manuscript Received: 11 SEP 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (358K)

REFERENCES

  • 1
    Hanson MN, Morrison VA, Peterson BA, Stieglbauer KT, Kubic VL, McCormick SR, et al. Posttransplant T-cell lymphoproliferative disorder—an aggressive, late complication of solid-organ transplantation. Blood 1996; 88: 3626–3633.
  • 2
    Jaffe ES, Ralfkiaer E. Hepatosplenic T-cell lymphoma. In: JaffeES, HarrisNL, SteinH, VardimanJW, eds. World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press; 2001: 210.
  • 3
    Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000; 14: 991–997.
  • 4
    Belhadj K, Reyes F, Farcet J-P, Tilly H, Bastard C, Angonin R, et al. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102: 4261–4269.
  • 5
    Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001; 3: 70–78.
    Direct Link:
  • 6
    LaCasce AS. Post-transplant lymphoproliferative disorders. Oncologist 2006; 11: 674–680.
  • 7
    Andreone P, Gramenzi A, Lorenzini S, Biselli M, Cursaro C, Pileri S, et al. Posttransplantation lymphoproliferative disorders. Arch Intern Med 2003; 163: 1997–2004.
  • 8
    Jain A, Nalesnik M, Reyes J, Pokhama R, Mazarlegos G, Green M, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 2002; 236: 429–436.
  • 9
    Harris NL, Swerdlow S, Frizzera G, Knowles DM. Post-transplant lymphoproliferative disorders. In: JaffeES, HarrisNL, SteinH, VardimanJW, eds. World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press; 2001: 264–269.
  • 10
    Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, et al. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol 2005; 23: 7574–7582.
  • 11
    Hézode C, Duvoux C, Germanidis G, Roudot-Thoraval F, Vincens A-L, Gaulard P, et al. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology 1999; 30: 775–778.
    Direct Link:
  • 12
    Morton LM, Landgren O, Chatterjee N, Castenson D, Parsons R, Hoover RN, et al. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood 2007; 110: 4599–4605.
  • 13
    De Wolf-Peeters C, Achten R. γδ T-cell lymphomas: a homogenous entity? Histopathology 2000; 36: 294–305.
    Direct Link:
  • 14
    Alonsozana EL, Stamberg J, Kumar D, Jaffe ES, Medeiros LJ, Frantz C, et al. Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic γδ T cell lymphoma. Leukemia 1997; 11: 1367–1372.
  • 15
    Przybylski GK, Wu H, Macon WR, Finan J, Leonard DGB, Felgar RE, et al. Hepatosplenic and subcutaneous panniculitis-like γ/δ T cell lymphomas are derived from different Vδ subsets of γ/δ T lymphocytes. J Mol Diagn 2000; 2: 11–19.
  • 16
    Suarez F, Wlodarska I, Rigal-Huguet F, Mempel M, Martin-Garcia N, Farcet J-P, et al. Hepatosplenic αβ T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of γδ hepatosplenic T-cell lymphoma. Am J Surg Pathol 2000; 24: 1027–1032.
  • 17
    Bank I, Duvdevani M, Livneh A. Expansion of γδ T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 2003; 141: 33–40.
  • 18
    Aljurf M, Ezzat A, O Musa M. Emerging role of γδ T-cells in health and disease. Blood Rev 2002; 16: 203–206.
  • 19
    Saito T, Matsuno Y, Tanosaki R, Watanabe T, Kobayashi Y, Tobinai K. γδ T-cell neoplasms: a clinicopathological study of 11 cases. Ann Oncol 2002; 13: 1792–1798.
  • 20
    Hviid L, Akanmori BD, Loizon S, Kurtzhals JAL, Ricke CH, Lim A, et al. High frequency of circulating γδ T cells with dominance of the Vδ1 subset in a healthy population. Int Immunol 2000; 12: 797–805.
  • 21
    Ohshima K, Haraoka S, Harada N, Kamimura T, Suzumiya J, Kanda M, et al. Hepatosplenic γδ T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology 2000; 36: 127–135.
    Direct Link:
  • 22
    Tseng C-TK, Miskovsky E, Houghton M, Klimpel GR. Characterization of liver T-cell receptor γδ T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 2001; 33: 1312–1320.
    Direct Link:
  • 23
    Jones D, Vega F, Sarris A, Medeiros LJ. CD4- CD8- ‘double-negative’ cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. Am J Surg Pathol 2002; 26: 225–231.
  • 24
    Narazaki H, Watari E, Shimizu M, Owaki A, Das H, Fukunaga Y, et al. Perforin-dependent killing of tumor cells by Vγ1Vδ1-bearing T-cells. Immunol Lett 2003; 86: 113–119.
  • 25
    Salhany KE, Feldman M, Peritt D, Nowell PC. Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in γδ hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders. Blood 1997; 89: 3490–3491.
  • 26
    Macon WR, Levy NB, Kurtin PJ, Salhany KE, Elkhalifa MY, Casey TT, et al. Hepatosplenic αβ T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic γδ T-cell lymphomas. Am J Surg Pathol 2001; 25: 285–296.
  • 27
    Falini B, Flenghi L, Pileri S, Pelicci P, Fagioli M, Martelli MF, et al. Distribution of T cells bearing different forms of the T cell receptor γ/δ in normal and pathological human tissues. J Immunol 1989; 143: 2480–2488.
  • 28
    Weidmann E, Hinz T, Klein S, Schui DK, Harder S, Kriener S, et al. Cytotoxic hepatosplenic γδ T-cell lymphoma following acute myeloid leukemia bearing two distinct γ chains of the T-cell receptor. Biologic and clinical features. Haematologica 2000; 85: 1024–1031.
  • 29
    Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology 2001; 259–281.
  • 30
    Dinçol G, Nalçaci M, Yavuz AS, Keskin H, Aktan M, Dogan Ö, et al. Case of hepatosplenic γδ T-cell lymphoma presenting with severe hypersplenism. Am J Hematol 1999; 60: 313–314.
    Direct Link:
  • 31
    Nosari A, Oreste PL, Biondi A, Constantini MC, Santoleri L, Intropido L, et al. Hepato-splenic γδ T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome. Am J Hematol 1999; 60: 61–65.
    Direct Link:
  • 32
    Sallah S, Smith SV, Lony LCL, Woodard P, Schmitz JL, Folds JD. Gamma/delta T-cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia. Ann Hematol 1997; 74: 139–142.
  • 33
    Blakolmer K, Gaulard P, Mannhalter C, Swerdlow S, Fassati LR, Rossi G, et al. Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft. Transplantation 2000; 70: 1802–1805.
  • 34
    Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic γδ T-cell origin. Blood 1996; 88: 4265–4274.
  • 35
    Macon WR, Williams ME, Greer JP, Hammer RD, Glick AD, Collins RD, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996; 87: 1474–1483.
  • 36
    Mason J, O'Leary T. Effects of formaldehyde fixation on protein secondary structure: a calorimetric and infrared spectroscopic investigation. J Histochem Cytochem 1991; 39: 225–229.
  • 37
    Rossbach H-C, Chamizo W, Dumont D, Barbosa J, Sutcliffe M. Hepatosplenic γ/δ T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl. J Pediatr Hematol Oncol 2002; 24: 154–157.
  • 38
    Wlodarska I, Martin-Garcia N, Achten R, De Wolf-Peeters C, Pauwels P, Tulliez M, et al. Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 2002; 33: 243–251.
    Direct Link:
  • 39
    Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kobayashi T, et al. Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma. Leuk Lymphoma 2007; 48: 630–632.
  • 40
    Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999; 68: 1517–1525.
  • 41
    Ganne V, Siddiqi N, Kamaplath B, Chang C-C, Cohen EP, Bresnahan BA, et al. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. Clin Transpl 2003; 17: 417–422.
    Direct Link:
  • 42
    Yedibela S, Reck T, Niedobitek G, Gramatzki M, Repp R, Hohenberger W, et al. Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantation. Transpl Int 2003; 16: 197–201.
    Direct Link:
View Full Article (HTML) Get PDF (358K)